Mindfulness Meditation in Hemodialysis Patients

N/ARecruitingNCT07620990

Cyprus Aydin University50 enrolled

Overview

This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.

This study is designed as a randomized controlled experimental trial conducted in hemodialysis units in Northern Cyprus. Hemodialysis patients will be randomly assigned to intervention and control groups.The intervention group will participane in a structured 4 week mindfulness meditation program delivered through guided sessions, while the control group will continue receiving routine care. The study aims to determine the effectiveness of mindfulness meditation on sleep quality, stress levels and symptoms management in hemodialysis patients. Data will be collected before and after the intervention using validated assessment scales.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Hemodialysis Stress Sleep Quality Symptom

Interventions

Mindfulness Meditation ProgramBEHAVIORAL

Participants in the intervention group will receive a 4 week mindfulness meditation program consisting of weekly guided mindfulness sessions and home practices. The program is designed to improve sleep quality, reduce stress levels, and manage symptoms in hemodialysis patients.

Routine CareOTHER

Participants in the control group will receive routine care provided in the hemodialysis unit without mindfulness meditation intervention.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged between 18 and 75 years * Patients receiving hemodialysis treatment for at least 3 months * Patients with cognitive functions suitable for the intervention (dementia score ≥21) * Patient without hearing, vision or communication problems * Patients without a psychiatric diagnosis * Patients able to use a smartphone or tablet * Patients not participating in another study * Patients not using sleep medication or antipsychotic drugs Exclusion Criteria: * Patients younger than 18 years or older than 75 years * Patients receiving hemodialysis treatment for less than 3 months * Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21) * Patient with hearing, vision or communication disabilities * Patients diagnosed with psychiatric disorders * Patients unable to use a smartphone or tablet * Patients participating in another study * Patients using sleep medication or antipsychotic drugs

Locations (4)

Famagusta State Hospital

Famagusta, Cyprus

RECRUITING

Dr. Akçiçek State Hospital

Kyrenia, Cyprus

RECRUITING

Cengiz Topel State Hospital

Lefka, Cyprus

RECRUITING

Outcomes

Primary Outcomes

Pittsburgh Sleep Quality İndex (PSQİ) Score

Pittsburgh Sleep Quality İndex (PSQİ) will be used to assess sleep quality in hemodialysis patients receiving mindfulness meditation intervention. The total PSQİ score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

Time frame: Baseline and 4 weeks after intervention

Perceived Stress Scale (PSS) Score

The Perceived Stress Scale (PSS) will be used to assess stress levels in hemodialysis patients receiving mindfulness meditation intervention. Scores range from 0 to 40, with higher scores indicating higher perceived stress.

Time frame: Baseline and 4 week after intervention.

Dialysis Symptom İndex (DSİ)

TheDialysis Symptom İndex (DSİ) will be used to assess symptom burden in hemodialysis patients receiving mindfulness meditation intervention. The total score ranges from 0 to 150, with higher scores indicating greater symptom burden.

Time frame: Baseline and 4 weeks after intervention.

Central Contacts

Sevda Sahin, RN, PhD Candidate

CONTACT

+905488488005 sevda0584@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.